These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9579567)

  • 41. Effects of tamoxifen on the human female genital tract: review of the literature.
    Varras M; Polyzos D; Akrivis Ch
    Eur J Gynaecol Oncol; 2003; 24(3-4):258-68. PubMed ID: 12807236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study.
    Wu CT; Lai JN; Tsai YT
    PLoS One; 2014; 9(12):e113887. PubMed ID: 25485843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case].
    Fambrini M; Buccoliero AM; Pieralli A; Andersson KL; Mattei A; Scarselli G; Taddei G; Marchionni M
    Minerva Ginecol; 2011 Oct; 63(5):465-70. PubMed ID: 21926955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of tamoxifen on the endometrium.
    Barakat RR
    Oncology (Williston Park); 1995 Feb; 9(2):129-34; discussion 139-40, 142. PubMed ID: 8771096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overview of studies on endometrial cancer and other types of cancer in humans: perspectives of an epidemiologist.
    MacMahon B
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-122-S1-39. PubMed ID: 9045310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endometrial cancer and recurrence with hormonal manipulation.
    Ghosh P; Fawzi H
    J Obstet Gynaecol; 2004 Feb; 24(2):192-3. PubMed ID: 14766474
    [No Abstract]   [Full Text] [Related]  

  • 51. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
    Behtash N; Hashemi R; Karimi Zarchi M
    Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of tamoxifen treatment on the endometrium.
    Daniel Y; Inbar M; Bar-Am A; Peyser MR; Lessing JB
    Fertil Steril; 1996 Jun; 65(6):1083-9. PubMed ID: 8641477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 55. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tamoxifen, screening and new oestrogen receptor modulators.
    Neven P; Vergote I
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
    Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
    BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.